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(AASM2007Alt) classifications. Data are presented as mean (standard deviation) if normally distributed,
and as median (interquartile range) if non-normally distributed. Results: The PSGs of 34 elderly [aged 67
(7.0) years] and predominantly male (m:f, 31:3) patients with COPD [FEV1%pred 48.4% (19.6%)] were
analysed. The AHI using AASM2007Rec criteria was 5.9 (2.0, 15.1) events/hour vs. 20.4 (11.5, 28.0)
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arousal. Although statistically non-significant, using the AASM2007Alt classification, 12% of our cohort
would not have been diagnosed with COPD/OSA overlap syndrome (P=0.114), this was also the case for
47% of the cohort when the AASM2007Rec classification was used (P<0.01). Conclusions: The use of
the AASM2012 scoring rules results in a significantly higher AHI compared to the AASM2007 criteria in
patients with COPD/OSA overlap syndrome, mostly due to an increased number of arousal-associated
hypopnoeas. These observations are important for the definition of the COPD/OSA overlap syndrome.
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Background: In 2007 and 2012, the American Academy of Sleep Medicine (AASM) updated their scoring 
criteria for nocturnal respiratory events. We hypothesised that this could have led to changes in the apnoea-
hypopnoea index (AHI) of patients with chronic obstructive pulmonary disease (COPD)/obstructive sleep 
apnoea (OSA) overlap syndrome.
Methods: In a retrospective study, polysomnographic (PSG) recordings of 34 patients with COPD/OSA 
overlap syndrome were independently analysed using the AASM criteria from 2007 (AASM2007) and 2012 
(AASM2012). The primary outcome was the difference in AHI, the secondary outcomes were frequency 
of hypopnoeas, diagnosis of overlap syndrome and differences between the AASM 2007 recommended 
(AASM2007Rec) and altered (AASM2007Alt) classifications. Data are presented as mean (standard deviation) if 
normally distributed, and as median (interquartile range) if non-normally distributed.
Results: The PSGs of 34 elderly [aged 67 (7.0) years] and predominantly male (m:f, 31:3) patients with 
COPD [FEV1%pred 48.4% (19.6%)] were analysed. The AHI using AASM2007Rec criteria was 5.9 (2.0, 15.1) 
events/hour vs. 20.4 (11.5, 28.0) events/hour using the 2012 criteria (P<0.001); with the AASM2007Alt criteria, 
the AHI was 15.0 (9.3, 26.3) events/hour (P<0.001). Using the 2012 classification, the number of scored 
hypopnoeas increased by +48% compared to the AASM2007Rec criteria (P<0.001), 92% of these events were 
associated with arousal. Although statistically non-significant, using the AASM2007Alt classification, 12% of our 
cohort would not have been diagnosed with COPD/OSA overlap syndrome (P=0.114), this was also the case 
for 47% of the cohort when the AASM2007Rec classification was used (P<0.01).
Conclusions: The use of the AASM2012 scoring rules results in a significantly higher AHI compared to 
the AASM2007 criteria in patients with COPD/OSA overlap syndrome, mostly due to an increased number 
of arousal-associated hypopnoeas. These observations are important for the definition of the COPD/OSA 
overlap syndrome.
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Introduction
Sleep-disordered breathing is a common problem in the 
general population, the most common form of which is 
obstructive sleep apnoea (OSA) (1,2). In addition, chronic 
obstructive pulmonary disease (COPD) affects more than 
250 million people according to a recent report (3). A high 
prevalence of the combination of both COPD and OSA has 
been reported since its description as “overlap syndrome” 
by Flenley in 1985 (4,5).
The apnoea-hypopnoea index (AHI) is a key component 
in the diagnosis, the classification of severity and the 
assessment of any treatment response of sleep-disordered 
breathing, in particular of OSA (6). However, the criteria 
for scoring apnoeas and hypopnoeas, which are required to 
calculate the AHI, have recently changed, particularly for 
hypopnoea events (7).
In 2007, the American Academy of Sleep Medicine 
(AASM) published the manual for the scoring of sleep and 
associated events mostly adopted in clinical practice, which 
included “recommended” (AASM2007Rec) and “alternative” 
(AASM2007Alt) scoring criteria (8). The hypopnoea definitions 
of AASM2007Rec require a reduction of 30% or more in the 
nasal pressure signal, associated with a ≥4% desaturation, 
and those of AASM2007Alt require a 50% or more reduction 
in nasal pressure signal associated with a ≥3% desaturation 
or an arousal. With the objective of improvement, the 
AASM published an update of the 2007 manual in 2012 
(known as the AASM2012 Manual), particularly considering 
the implications for lean people and OSA associated 
outcomes (7). The AASM2012 criteria recommendations 
define the scoring criteria for a hypopnoea in case of a 
≥30% reduction in nasal pressure flow associated with a 
≥3% desaturation or an arousal.
Since then, several studies have assessed the impact of 
different hypopnoea definitions on the AHI and diagnosis 
of OSA in the general population (9,10). BaHammam et al. 
demonstrated that the AASM2012 criteria could lead to a 
higher AHI when compared to the AASM2007 criteria (10). 
Recently, Duce et al. further confirmed that the AASM2012 
criteria were generally associated with higher AHIs than 
the 2007 criteria, but led to similar AHI and diagnostic 
outcomes as the 1999 manual (9). In a large population-
based study using home polysomnography (PSG) in more 
than 2,000 people, applying different scoring rules for 
hypopnoea resulted in a large difference in the prevalence 
of OSA and a twofold difference in an AHI threshold 
associated with hypertension (11).
However, there are no studies to report the impact of the 
changed classification on the AHI and diagnosis of OSA in 
patients with COPD, the COPD/OSA overlap syndrome. 
Generally, COPD patients with severe emphysema may be 
more likely to be lean and elder than the general population 
and, due to a lower oxygen saturation and hypoventilation, 
more prone to frequent nocturnal oxygen desaturations. 
Thus, we hypothesised that the AASM2012 criteria could 
have led to significant changes in the AHI and the diagnosis 
of patients with COPD associated OSA due to a change 
in the definition of hypopnoea. We present the following 
article/case in accordance with the STROBE reporting 
checklist (available at http://dx.doi.org/10.21037/jtd-
cus-2020-008).
Methods
This was a retrospective study preformed in the Sleep 
Disorders Centre at Guy’s & St Thomas’ NHS Foundation 
Trust, King’s College London, UK and the First Affiliated 
Hospital of Guangzhou Medical University. All consecutive 
stable patients diagnosed with COPD by respiratory 
specialists (post-bronchodilator FEV1/FVC ratio of <0.7) 
and OSA (AHI ≥5 events/hour in an overnight PSG) 
between August 2013 and April 2019 were eligible. In 
the British cohort, all patients with COPD/OSA Overlap 
Syndrome who underwent PSG between August 2013 
and April 2019 were screened, but in the Chinese cohort, 
the first 26 patients screened backwards were selected. To 
ensure a reliable analysis, patients were not included if any 
primary PSG channel (nasal pressure, pulse oximetry, all 
EEG, respiratory effort) contained artefacts during more 
than 30% of total sleep time, or the total sleep time was 
too short (<2.8 hours). This study was approved by the 
review board of Guy’s & St Thomas’ NHS Foundation 
Trust of King’s College London and the First Affiliated 
Hospital of Guangzhou Medical University (the registered 
service review: 2019/9662). This retrospective study was 
conducted in accordance with the Declaration of Helsinki 
(as revised in 2013). The requirement for informed consent 
was waived because of the retrospective study design. All 
eligible patients were reviewed by a respiratory consultant 
through the ‘electronic patient record’ system to obtain 
basic information such as age, body mass index (BMI), 
spirometry (forced expiratory volume in 1 s (FEV1), forced 
vital capacity (FVC) and the ratio of FEV1 to FVC (FEV1/
FVC)) and Epworth sleepiness scale (ESS). The PSG data 
of all eligible patients were re-analysed by experienced sleep 
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technicians.
Outcome parameters
The primary outcome of this retrospective study was the 
difference in AHI using 2007 vs. 2012 criteria. Secondary 
outcomes were frequency of hypopnoeas, diagnosis of 
overlap syndrome, and differences between the AASM 
2007 recommended (AASM2007Rec) and altered (AASM2007Alt) 
classifications.
Polysomnography recording and scoring
Inpatient PSGs were recorded in the sleep laboratory 
using Rembrandt polysomnography system (Embla, 
Broomfield, CO, USA) in the UK, and Alice 5 diagnostic 
equipment (Respironics Inc., Murrysville, PA, USA) in 
China. The recording montage consisted of EEG (F3A2, 
F4A1, C3A2, C4A1, O1A2, O2A1), eye movements 
(E1M2 & E2M1), muscle tone (electromyogram of 
chin and both legs), oxygen saturation (finger pulse 
oximeter), chest and abdominal wall movement (thoracic 
and abdominal inductance plethysmography), airflow 
(thermistor and nasal pressure transducer), and snoring 
(microphone). Sleep stages and arousals of the British 
cohort (n=8) and the Chinese cohort (n=26) were analyzed 
by a trained PSG scorer (UK: SH, China: YXW). These 
PSGs were randomly assigned to three PSG scorers 
(BTH, MS, YXW) to be re-analysed for respiratory 
events. Respiratory events were independently re-
analysed three times in random order, and scored using 
either the AASM2007Rec, AASM2007Alt or AASM2012 criteria. 
The hypopnoea definitions of AASM2007Rec require a 
reduction of 30% or more in the nasal pressure signal, 
associated with a ≥4% oxygen desaturation, and those of 
AASM2007Alt require a ≥50% reduction in nasal pressure 
signal associated with a ≥3% desaturation or an arousal (8). 
The AASM2012 criteria recommendations define the 
scoring criteria for a hypopnoea as a ≥30% reduction in 
nasal pressure flow associated with a ≥3% desaturation or 
an arousal (7).
Statistical analysis
Statistical analysis was performed using SPSS 16.0 (Chicago, 
IL/USA) following collection of the data in MS Excel 2010 
(Microsoft, Seattle, WA/USA). The data are presented as 
mean [standard deviation (SD)] if normally distributed, 
and as median [interquartile range (IQR)] if non-normally 
distributed. Group data were compared using the paired 
t-test or the Friedman test, with the Tukey’s honestly 
significant difference (HSD) post hoc test for multiple 
comparisons. The diagnosis of OSA and severity of disease 
in the patient cohort, as defined by using the different 
scoring criteria, were compared using the Chi-Square 
test. The agreement of the different criteria was further 
compared using Bland-Altman plots. Stepwise multiple 
linear regression analysis was performed to investigate 
predictors of the AHI (2012 vs. 2007Alt, 2012 vs. 2007Rec) 
including age, gender, BMI, and severity of COPD. In all 
analyses, a P<0.05 was considered statistically significant.
Results
Patient characteristics
Seven patients’ PSGs were excluded due to bad signals of 
PSGs (n=4) and the lack of spirometry result (n=3). Thirty-
four patients were included in the analysis. A summary of 
patient’s characteristics and PSG results are presented in 
Table 1. The 26 patients from China were older (69±5 vs. 
61±10 years, P<0.01) and leaner (BMI, 20±3 vs. 33±9 kg/m2, 
P<0.001), and had more severe airway obstruction (FEV1 
%pred, 45%±14% vs. 60%±30%, P=0.046) than the eight 
patients from the UK.
Differences in AHI and hypopnoea-index (HI) according to 
scoring criteria
The AHI and HI were significantly different between 
AASM2012 criteria, AASM2007Alt and AASM2007Rec (P<0.001; 
Table 2). The AASM2012 criteria resulted in an increase 
in the AHI of 12% (9%, 26%) and 64% (38%, 86%) 
compared to AASM2007Alt and AASM2007Rec, respectively. 
Bland-Altman analyses for AHI2012, AHI2007Alt and AHI2007Rec 
showed a bias of 3.5 (95% CI, −2.0 to 8.9) events/hour and 
11.7 (95% CI, −1.0 to 24.4) events/hour in the AASM2012 
criteria when compared to AASM2007Alt and AASM2007Rec, 
respectively (Figure 1). There was an increase of 25% in 
the number of hypopnoeas scored by the AASM2012 criteria 
when compared to AASM2007Alt (P<0.001) due to the 
change of rules from ≥50% to ≥30% flow reduction. The 
AASM2012 criteria resulted in an increase in the number of 
hypopnoeas events of 48% compared to the AASM2007Rec 
criteria (P<0.001); 92% of these events were associated 
with arousal.
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Table 1 Summary of demography, spirometry and polysomnography 
result










Total sleep time (h) 4.7±1.1
Sleep efficiency (%) 57.2±14.5
Stage N1 (%) 31.1±16.5
Stage N2 (%) 44.1±16.2
Stage N3 (%) 8.2±13.4
Stage R (%) 16.5±6.9
AI (events/h) 23.5±9.7
4% ODI (events/h) 12.0±15.3
Wake SpO2 (%) 94.7±1.7
Mean SpO2 (%) 94.0±2.3
Nadir SpO2 (%) 86.4±5.6
Time with SpO2 <90% (min) 21.8±37.9
% of TST with SpO2 <90% (%) 6.7±11.1
SD, standard deviation; ESS, Epworth Sleepiness Scale; FEV1, 
forced expiratory volume in 1 second; FVC, forced vital capacity;  
AI, arousal index; ODI, oxygen desaturation index.
Table 2 AHI and HI using the AASM2012, AASM2007Alt, or AASM2007Rec criteria
Parameter AASM2012 AASM2007Alt AASM2007Rec P
AHI (events/hour) 20.4 (11.5, 28.0) 15.0 (9.3, 26.3) 5.9 (2.0, 15.1) <0.001
HI (events/hour) 16.1 (10.1, 21.3) 11.8 (8.0, 17.9) 2.4 (0.68, 6.9) <0.001
Data were presented as median (interquartile range). AASM, American Academy of Sleep Medicine; AHI, apnoea-hypopnoea index; HI, 
hypopnoea index.
Figure 1 Bland-Altman agreement plots. The thick line represents 
the mean difference. The dashed lines represent ±1.96 standard 
deviation.
OSA diagnosis
Using the AASM2007Rec classification, 48% of the AASM2012 
overlap syndrome cohort would not have been diagnosed 
with COPD/OSA overlap syndrome if using the diagnostic 
criteria of an AHI ≥5 events/hour (P<0.01); this was also 
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Table 3 Patient diagnosis according to hypopnoea criteria
Diagnosis AASM2012 AASM2007Alt AASM2007Rec
No OSA 0 4 (11.8%) 16 (47.1%)*
Mild OSA 12 (35.3%) 13 (38.2%) 9 (26.5%)
Moderate OSA 15 (44.1%) 12 (35.3%) 7 (20.6%)*
Severe OSA 7 (20.6%) 5 (14.7%) 2 (5.9%)
Values presented as absolute number of diagnoses (% of total number of patients). *, P<0.05 compared to AASM2012. AASM, American 
Academy of Sleep Medicine; OSA, obstructive sleep apnoea.
Table 4 Stepwise multiple linear regression analysis of the discrepancy in the AHI (2012 vs. 2007Alt, 2012 vs. 2007Rec) (n=33)
Dependent variable
Statistically significant  
independent variables
B SE B P value
Non-significant  
independent variables
P value△AHI2012-2007Alt BMI 0.190 0.054 0.001 Age 0.179
Gender 4.165 1.455 0.008
Severity of COPD −1.356 0.530 0.016△AHI2012-2007Rec BMI −0.362 0.138 0.013 Age 0.781
Gender −9.355 3.931 0.024 Severity of COPD 0.218
B, the standardized regression coefficient; SE B, the standard error of beta; △AHI2012-2007Alt, the discrepancy in the AHI between the 2012 
criteria and the 2007Alt criteria; △AHI2012-2007Rec, the discrepancy in the AHI between the 2012 criteria and the 2007Rec criteria; severity of 
COPD, classification by post-bronchodilator spirometry (1: FEV1 %pred ≥80%; 2: FEV1 %pred 50% to 79%; 3: FEV1 %pred 30% to 49%; 4: 
FEV1 %pred <30%); AHI, apnoea-hypopnoea index; BMI, body mass index; COPD, chronic obstructive pulmonary disease.
classification was used (P=0.114). Moreover, 38% of our 
cohort were above the threshold for moderate OSA with an 
AHI of 15 events/hour using the AASM2012, but not when 
using the AASM2007Rec classification (P<0.05; Table 3).
Multiple linear regression analysis
A stepwise multiple linear regression analysis was performed 
to investigate predictors of differences in the AHI (2012 
vs. 2007Alt, 2012 vs. 2007Rec) entering age, gender, 
BMI, severity of COPD (Table 4). The regression model 
(F=13.199, P<0.001) showed that about 58% of the variation 
between AHI2012 and AHI 2007Alt (R2=0.577, P<0.001) 
was explained by the BMI (P=0.001), gender (P=0.008) and 
severity of COPD (P=0.016). About 33% of the variation 
between the AHI2012 and AHI2007Rec (R2=0.330, P<0.05) 
was associated with BMI (P=0.013) and gender (P=0.024) 
(F=7.382, P<0.05).
Chinese and UK cohort
For patients with COPD from the UK, the AHI using 
AASM2007Alt criteria was significantly lower than when using 
AASM2007Rec criteria [4.8 events/hour (1.8, 10.7) vs. 12.8 
events/hour (5.8, 15.5), P<0.001]. Using the AASM2007Alt 
classification, the percentage of the British cohort that 
would not have been diagnosed as COPD/OSA overlap 
syndrome (AHI ≥5 events/hour) was 38% while this was 
true for 25% (P=0.5) using the AASM2007Rec classification. 
In contrast to the British cohort, the AHI in the Chinese 
cohort using AASM2007Alt criteria was significantly higher 
than when using AASM2007Rec criteria [30.2 events/hour 
(21.9, 42.2) vs. 18.2 events/hour (17.1, 37.8), P<0.001]. 
Using the AASM2007Alt classification, the percentage of 
the Chinese cohort that would not have been diagnosed 
as COPD/OSA overlap syndrome (AHI ≥5 events/hour) 
was significantly lower than when using the AASM2007Rec 
classification (4% vs. 54%, P<0.001).
Discussion
The introduction of the AASM2012 scoring rules resulted in a 
significantly higher AHI compared to the AASM2007 criteria 
in patients with COPD/OSA overlap syndrome. This was 
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largely due to an increased number of arousal-associated 
hypopnoeas, and a significantly larger proportion of patients 
diagnosed with OSA when compared to AASM2007Rec 
rather than AASM2007Alt. In contrast to the overall trend 
the increase in the AHI and the proportion of patients 
diagnosed with OSA in the British cohort using the 2012 
AASM criteria was when compared to AASM2007Alt, rather 
than AASM2007Rec. To the best knowledge of the authors, this 
is the first study to investigate the impact of the 2007 and 
2012 AASM scoring criteria on the AHI in COPD/OSA 
overlap syndrome.
Clinical significance of findings
Previous studies have focused on the difference between 
AASM2007Alt, AASM2007Rec, and AASM2012 in the general 
population and OSA, but not in patients with COPD (9,10). 
They found that implementation of the 2012 AASM criteria 
increased the AHI and the diagnosis of OSA. However, the 
effect of the rule changes on the hypopnoea index in our 
study in COPD/OSA overlap syndrome differs to previous 
studies. The study of Duce et al. demonstrated that the 
inclusion of EEG arousals contributed almost equally to 
the change in the hypopnoea index as the decrease in SpO2 
desaturation requirement (9). In our study, the contribution 
of EEG arousal was significantly larger than that of the 
decrease in SpO2 desaturation (92% vs. 8%) in COPD/OSA 
overlap syndrome. Bonnet et al. and Guilleminault et al. 
found that arousals are common in the elderly (12) and 
absence of SpO2 desaturation often occurs in lean OSA 
patients (13). Hence, these differences between our results 
and others may be partially explained by the characteristics 
of our cohort, with elderly and leaner patients.
The studies of Marin et al. and Weitzenblum et al. 
demonstrate that patients with the overlap syndrome who 
suffer from more severe hypoxaemia and hypercapnia, may 
have a worse prognosis and higher mortality compared 
to patients with either condition alone (14,15). However, 
there are conflicting data about the association of oxygen 
desaturations (16,17) and clinically important outcomes 
(18,19) in the COPD/OSA overlap syndrome. Soler’s and 
our previous studies showed that the prevalence of oxygen 
desaturations was similar between patients with isolated 
COPD and patients with overlap syndrome (16,17). 
Moreover, the clinical outcomes in patients on home 
mechanical ventilation for chronic respiratory failure is 
better in overlap syndrome compared to COPD alone in a 
recent report (18,19), with no difference in mortality (20).
This observation may be attributable to several factors. 
Different pathophysiological changes due to various 
phenotypes of overlap syndrome were reported in some 
studies (16). The change in the definition of hypopnoea by 
the AASM2012 criteria (7) could also result in an increased 
prevalence of overlap syndrome with predominant hypopnoea 
associated with arousals rather than severe desaturations, 
in particular for COPD patients according to the results 
of this study. Arousals are common in the elderly (12) 
which is a typical characteristic of patients with COPD. 
Moreover, a decrease of neural respiratory drive of COPD 
patients increases the chance of occurrence of hypopnoeas 
and hypoventilation (16,21). Thus, we believe that COPD 
patients have many hypopnoeas that are distinct from other 
nocturnal respiratory events caused by a collapsible upper 
airway in OSA, especially when hypopnoeas are scored 
based on a flow reduction accompanied by an arousal. In 
a study by Du et al., OSA did not significantly impact on 
the mortality of patients with COPD (20). A recent cohort 
study suggested that COPD/OSA overlap syndrome is 
associated with a better prognosis than COPD alone (18,19). 
Hence, we should be careful to diagnose COPD/OSA 
overlap syndrome and treatment implications.
Although these were small cohorts, there was an 
inverse trend in the Chinese and British cohorts between 
AASM2007Rec and AASM2007Alt. Our study demonstrated 
that the AHI using AASM2007Alt criteria was significantly 
lower than when using AASM2007Rec criteria in the Chinese 
cohort, but significantly higher in the British cohort. In 
other words, the hypopnoeas that occurred in the British 
cohort were mostly associated with desaturations rather 
than arousals. This difference might be explained by 
different phenotypes of COPD, such as pink puffers or blue 
bloaters (22,23). COPD patients with lower daytime SpO2 
are also more likely to experience more severe nocturnal 
desaturations (24). In our study, the British cohort was 
more represented by “blue bloaters” with higher BMI and 
lower daytime SpO2 but also more preserved FEV1 than the 
Chinese cohort, which included more “pink puffers”.
Limitations
This study represented a small sample, in particular of any 
comparison between Chinese and British patients. Although 
we selected patients with COPD/OSA overlap syndrome 
diagnosed by the criteria using an “AHI ≥5 events/hour”, 
there were limited subjects who were eligible for this study. 
The requirement of full PSG including the EEG signal 
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could be the main reason. Portable sleep monitors without 
EEG signal might be easier to use in the general population 
and in COPD patients to diagnose and assess patients with 
COPD/OSA overlap syndrome. Notwithstanding the above 
limitations, our study demonstrated that there was a clear 
effect of the new classification on the diagnosis of COPD/
OSA overlap syndrome.
Conclusions
In summary, this study has demonstrated that the use of the 
AASM2012 scoring rules results in a significantly higher AHI 
compared to the AASM2007 criteria in patients with COPD/
OSA overlap syndrome. The increase of hypopnoeas in 
patients with COPD/OSA overlap syndrome is mostly 
associated with arousals rather than desaturations. These 
findings should be considered in diagnosing COPD/OSA 
overlap syndrome and treatment decisions in these patients.
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